Top Experts will Join COR2ED at #ASCO25 for Rapid Video Insights on Late-Breaking Data, stay tuned for some Great Insights LINK: cor2ed.com/late-breaker-u… In a series of short videos coming soon, Prof. Gerhardt Attard, first author on the AMPLITUDE study, will share

🚨#ProstateCancer update from #ASCO25! 🚨 📊Insights on new data from the Phase 3 AMPLITUDE trial and a STAMPEDE Ancillary study From Prof. Gerhardt Attard (AttardLab) How will these data impact clinical practice? Watch to find out 📺 See more updates from ASCO 2025:

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY Coming soon: a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

Catch up on highlights from #ASCO25! Experts joined us at ASCO to share their insights on how the latest data could change clinical practice ➡️ Prof. Mark Socinski: #NSCLC (downloadable slides also available) ➡️ Dr AttardLab: #ProstateCancer ➡️ Dr Lizzy Smyth: #GastricCancer

How is molecular classification transforming prognosis and personalising treatment in endometrial cancer? Find out here: cor2ed.com/obstetrics-gyn… #MedEd #Oncology #PrecisionMedicine #OBGYN This educational programme is sponsored by an Independent Educational Grant from Eisai

🎉COR2ED has over 12k subscribers on YouTube! 🎉 Do you follow us? ▶️youtube.com/@cor2edthehear… Join over 12k HCPs on our YouTube channel and stay up to date with #MedEd videos as they’re released 🎓 #MedicalEducation #Oncology #GUtwitter #OncologyNursing #CancerNurses

Coming soon… An interactive case with Prof. Gunhild von Amsberg on shared decision-making for men with mCRPC. The patient case explores early intensification strategies and practical communication tools. Stay tuned for: 🔹 Practical SDM tools 🔹 Early treatment

New patient case video from our partner physician group GU CONNECT 📺 Shared decision-making for mCRPC patients: PART 1 -> Explore early treatment intensification with a PARPi plus ARPI combination -> Discover the 5-step SHARE Communication Framework to support shared

New patient case video from our partner physician group GU CONNECT! 📺 Shared decision-making for mCRPC patients: PART 2 Uro-Oncologist Prof. Gunhild von Amsberg continues to explore early treatment intensification with a PARPi plus ARPI combination -> You’ll also discover

📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer & showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME #MedTwitter

📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer, and showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME

RCC update from #ESMO25! From our partner physician group GU CONNECT #MedEd

🚨 Update on new #BladderCancer data from #ESMO25! Will the data impact clinical practice? Watch the video from our partner physician group GU CONNECT to find out! #MedEd

THE #ESMO25 COMPLETE Newsletter by OncoAlert 🚨IS OUT NOW‼️ TO GET IT REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… 5⃣0⃣of our pick of TOP Trials Presented in Berlin🇩🇪Divided by Tumor Type and with great video coverage by our collaborators at COR2ED

🎉 COR2ED now has over 20,000 YouTube subscribers! 🎉 GU NURSES CONNECT is an initiative of COR2ED - come and find us on YouTube! Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes

Enhance patient discussions with the SHARE Communication Framework; a straightforward five-step guide to support shared, informed decision-making. Find out more in this interactive prostate cancer patient-case study video from experts in collaboration with GU CONNECT

In this interactive mCRPC case study from Prof. Gunhild von Amsberg for GU CONNECT you’ll learn how early treatment intensification with a PARPi plus ARPI can support improved outcomes. #ProstateOncology #PCSM

We are proud to share that more than 50,000 HCPs around the world follow COR2ED's programmes to stay up to date with the latest science, and provide their patients with the best possible care 🎉 ~ GU NURSES CONNECT is an initiative of COR2ED ~ 👏 Over 25k HCPs subscribe